AMERICAN INTERNATIONAL GROUP, INC. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$85,843
-56.5%
25,248
-6.0%
0.00%0.0%
Q2 2023$197,318
-29.8%
26,846
-1.0%
0.00%
-50.0%
Q1 2023$280,901
-11.7%
27,114
+0.6%
0.00%0.0%
Q4 2022$318,256
-44.2%
26,948
-0.7%
0.00%
-50.0%
Q3 2022$570,000
-31.7%
27,147
+1.0%
0.00%
-33.3%
Q2 2022$834,000
-27.4%
26,867
-4.0%
0.01%0.0%
Q1 2022$1,149,000
-11.0%
27,983
-5.8%
0.01%0.0%
Q4 2021$1,291,000
-76.3%
29,704
-72.6%
0.01%
-79.3%
Q3 2021$5,437,000
-19.9%
108,595
+0.7%
0.03%
+26.1%
Q2 2021$6,790,000
-34.0%
107,795
-2.6%
0.02%
-36.1%
Q1 2021$10,283,000
+4.2%
110,674
+0.5%
0.04%
-2.7%
Q4 2020$9,867,000
-12.0%
110,121
+1.4%
0.04%
-31.5%
Q3 2020$11,218,000
+349.4%
108,565
+243.9%
0.05%
+350.0%
Q2 2020$2,496,000
+38.2%
31,568
+1.1%
0.01%
+20.0%
Q1 2020$1,806,000
+2.1%
31,218
-4.8%
0.01%
+42.9%
Q4 2019$1,768,000
+0.6%
32,778
-2.6%
0.01%0.0%
Q3 2019$1,758,000
+6.5%
33,636
-1.5%
0.01%
+16.7%
Q2 2019$1,650,000
-4.8%
34,164
-0.5%
0.01%
-14.3%
Q1 2019$1,734,000
-17.0%
34,319
-2.6%
0.01%
-22.2%
Q4 2018$2,088,000
-9.1%
35,227
+1.0%
0.01%
+12.5%
Q3 2018$2,296,000
+37.0%
34,877
+5.1%
0.01%
+33.3%
Q2 2018$1,676,000
+48.6%
33,192
+55.0%
0.01%
+50.0%
Q1 2018$1,128,000
-9.5%
21,419
-20.2%
0.00%0.0%
Q4 2017$1,247,000
+15.4%
26,843
+0.5%
0.00%0.0%
Q3 2017$1,081,000
+26.3%
26,717
+5.8%
0.00%
+33.3%
Q2 2017$856,000
+47.3%
25,257
+26.2%
0.00%
+50.0%
Q1 2017$581,000
-26.6%
20,006
-17.0%
0.00%
-33.3%
Q4 2016$792,000
-99.9%
24,110
-1.5%
0.00%0.0%
Q3 2016$771,602,000
+14.5%
24,472
+2.1%
0.00%0.0%
Q2 2016$673,840,000
-19.5%
23,963
+4.1%
0.00%0.0%
Q1 2016$837,000,000
-5.4%
23,012
+4.0%
0.00%
-25.0%
Q4 2015$885,000,000
+141726.9%
22,120
+1.1%
0.00%
+33.3%
Q3 2015$624,000
-99.9%
21,870
+0.8%
0.00%0.0%
Q2 2015$714,950,000
+13.0%
21,698
-1.4%
0.00%0.0%
Q1 2015$632,950,000
+6.7%
22,008
+1.0%
0.00%0.0%
Q4 2014$593,178,000
+24.1%
21,784
-2.9%
0.00%
+50.0%
Q3 2014$478,047,000
-4.7%
22,433
+0.4%
0.00%0.0%
Q2 2014$501,869,000
-8.0%
22,345
+3.5%
0.00%
-33.3%
Q1 2014$545,706,000
+13.1%
21,595
+2.9%
0.00%
+50.0%
Q4 2013$482,376,000
+21.5%
20,982
+0.6%
0.00%0.0%
Q3 2013$397,135,000
+36.2%
20,847
+3.1%
0.00%0.0%
Q2 2013$291,688,00020,2280.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders